Balance Sheet Insights: Ovid Therapeutics Inc (OVID)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

In the latest session, Ovid Therapeutics Inc (NASDAQ: OVID) closed at $0.29 up 3.71% from its previous closing price of $0.28. In other words, the price has increased by $3.71 from its previous closing price. On the day, 1.25 million shares were traded.

Ratios:

For a deeper understanding of Ovid Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.93 and its Current Ratio is at 4.93. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.22.

On April 30, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $9.

On April 29, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $9.H.C. Wainwright initiated its Buy rating on April 29, 2024, with a $9 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 26 ’25 when ALEXANDER MARGARET A. sold 5,279 shares for $0.56 per share. The transaction valued at 2,956 led to the insider holds 73,406 shares of the business.

Rona Jeffrey A sold 3,902 shares of OVID for $2,185 on Feb 26 ’25. The CBFO now owns 67,973 shares after completing the transaction at $0.56 per share. On Jan 27 ’25, another insider, ALEXANDER MARGARET A., who serves as the President and COO of the company, bought 6,810 shares for $0.73 each. As a result, the insider paid 4,971 and bolstered with 34,935 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 37.56 while its Price-to-Book (P/B) ratio in mrq is 0.35.

Stock Price History:

Over the past 52 weeks, OVID has reached a high of $3.31, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is -2.74%, while the 200-Day Moving Average is calculated to be -61.37%.

Shares Statistics:

A total of 71.11M shares are outstanding, with a floating share count of 59.51M. Insiders hold about 16.32% of the company’s shares, while institutions hold 54.79% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.